During the verification, we utilized the gene knockout approach of CRISPR-Cas9 to examine their effect on transcriptions of MHC-I family genes, including HLA-A, HLA-B, HLA-C, and HLA-DOB, followed by analysis of MHC-I expression on tumor cell surfaces by the method of flow cytometry for further confirmation. This evidence concerns the gene HLA-C and neoplasm.